Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 843 shares at $44.61 ($37K) on 2017-02-07, disclosed to the SEC on 2017-02-08.
Scheduled sale ($37k) by Chief Regulatory Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.15 | 727 | $31K | 85.8% |
| 2 | $44.61 | 116 | $5K | 14.2% |
| Total | $43.35 avg | 843 | $37K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |